British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The US Patent Trial and Appeal Board, an administrative law body of the national patent...
25 October 2016 The report goes on to say… The marijuana plants, which are of a non-psychoactive variety, will be grown in British Sugar’s 18-hectare glasshouse in Wissington, Norfolk, where the company, a subsidiary of Associated British Foods, is currently...